If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Stefania Bregante is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 52 Similar Profiles
Transplants Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
Homologous Transplantation Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 2308 Citations
  • 30 h-Index
  • 59 Article
  • 1 Letter
2 Citations (Scopus)

Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group

Gruppo Italiano Trapianti di Midollo Osseo. (GITMO)., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Thiotepa
Busulfan
Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Multicenter Studies

Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group

Patriarca, F., Masciulli, A., Bacigalupo, A., Bregante, S., Pavoni, C., Finazzi, M. C., Bosi, A., Russo, D., Narni, F., Messina, G., Alessandrino, E. P., Carella, A. M., Milone, G., Bruno, B., Mammoliti, S., Fanin, R., Bonifazi, F., Rambaldi, A. & (GITMO)., G. I. T. D. M. O., 2019, In : Biology of Blood and Marrow Transplantation. 25, 5, p. 932-940 9 p.

Research output: Contribution to journalArticle

Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group

Gruppo Italiano Trapianti di Midollo Osseo. (GITMO)., Dec 20 2018, In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Thiotepa
Busulfan
Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Multicenter Studies
4 Citations (Scopus)

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Raj, K., Eikema, D. J., McLornan, D. P., Olavarria, E., Blok, H. J., Bregante, S., Ciceri, F., Passweg, J., Ljungman, P., Schaap, N., Carlson, K., Zuckerman, T., de Wreede, L. C., Volin, L., Koc, Y., Diez-Martin, J. L., Brossart, P., Wolf, D., Blaise, D., Bartolomeo, P. D. & 5 others, Vitek, A., Robin, M., Yakoub-Agha, I., Chalandon, Y. & Kroger, N., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Stem Cell Transplantation
Transplantation
Bone Marrow
Incidence